By Iain Gilbert
Date: Monday 13 Apr 2026
(Sharecast News) - Bioventix revealed on Monday that chairman Ian Nicholson had acquired 1,000 ordinary shares in the AIM-listed biotechnology firm.
By Iain Gilbert
Date: Monday 13 Apr 2026
(Sharecast News) - Bioventix revealed on Monday that chairman Ian Nicholson had acquired 1,000 ordinary shares in the AIM-listed biotechnology firm.
By Josh White
Date: Monday 27 Oct 2025
(Sharecast News) - Bioventix reported lower annual profits on Monday, as weakness in its core markets, particularly China, offset gains from growing demand for its neurological diagnostic antibodies.
| Currency | UK Pounds |
| Share Price | 1,750.00p |
| Change Today | -50.00p |
| % Change | -2.78 % |
| 52 Week High | 2,525.00p |
| 52 Week Low | 1,366.67p |
| Volume | 8,839 |
| Shares Issued | 5.22m |
| Market Cap | £91.44m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Latest | Previous | |
|---|---|---|
| Interim | 2nd Interim | |
| Ex-Div | 09-Apr-26 | 06-Nov-25 |
| Paid | 24-Apr-26 | 21-Nov-25 |
| Amount | 70.00p | 80.00p |
| Time | Volume / Share Price |
| 16:44 | 1,000 @ 1,764.00p |
| 16:24 | 152 @ 1,706.00p |
| 16:19 | 99 @ 1,726.20p |
| 15:59 | 200 @ 1,758.00p |
| 15:57 | 45 @ 1,800.00p |
| CEO | Peter John Harrison |
| Chair | Ian James Nicholson |
| CFO | Bruce Hiscock |
You are here: research